Conclusion
Due to a high variability of NT-proBNP levels in the absence of clinical
change in HFpEF patients, previous studies have raised concerns the
association between temporal trends in NT-proBNP disease worsening
clinical status in HFpEF may not be observed or may not be as strong as
in HFrEF. 10 We demonstrate a strong association
between 6-month survival and the overall temporal trend in NT-proBNP
values in both HFpEF and HFrEF patients. Up-trending NT-proBNP values
are associated with worse 6-month survival in both subsets of HF.
Conversely, downtrending NT-proBNP levels are associated with better
6-month survival rates.